Unknown

Dataset Information

0

Design and Synthesis of Novel Symmetric Fluorene-2,7-Diamine Derivatives as Potent Hepatitis C Virus Inhibitors.


ABSTRACT: Hepatitis C virus (HCV) is an international challenge. Since the discovery of NS5A direct-acting antivirals, researchers turned their attention to pursue novel NS5A inhibitors with optimized design and structure. Herein we explore highly potent hepatitis C virus (HCV) NS5A inhibitors; the novel analogs share a common symmetrical prolinamide 2,7-diaminofluorene scaffold. Modification of the 2,7-diaminofluorene backbone included the use of (S)-prolinamide or its isostere (S,R)-piperidine-3-caboxamide, both bearing different amino acid residues with terminal carbamate groups. Compound 26 exhibited potent inhibitory activity against HCV genotype (GT) 1b (effective concentration (EC50) = 36 pM and a selectivity index of >2.78 × 106). Compound 26 showed high selectivity on GT 1b versus GT 4a. Interestingly, it showed a significant antiviral effect against GT 3a (EC50 = 1.2 nM). The structure-activity relationship (SAR) analysis revealed that picomolar inhibitory activity was attained with the use of S-prolinamide capped with R- isoleucine or R-phenylglycine residues bearing a terminal alkyl carbamate group.

SUBMITTER: Mousa MHA 

PROVIDER: S-EPMC8064491 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4018120 | biostudies-literature
| S-EPMC7488290 | biostudies-literature
| S-EPMC6071962 | biostudies-literature
| S-EPMC7172530 | biostudies-literature
| S-EPMC8209122 | biostudies-literature
| S-EPMC4434481 | biostudies-literature
| S-EPMC6072533 | biostudies-literature
| S-EPMC10507801 | biostudies-literature
| S-EPMC2979143 | biostudies-literature
| S-EPMC3297913 | biostudies-literature